Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
crawled date : 2022 - 04 - 27 source : Www.biospace.com save search
SQZ Biotechnologies Receives FDA Fast Track Designation for its Lead Cell Therapy Candidate for the Treatment of HPV16+ Tumors
Published: 2022-04-27 (Crawled : 23:00) - biospace.com/
SQZ | $0.435 0.0% 30M
|
Health Technology
|
| O: -0.68%
H: 3.79%
C: -4.48%
hpv16 treatment fda designation sqz therapy fast track designation
Acutus Medical to Announce First Quarter 2022 Financial Results
Published: 2022-04-27 (Crawled : 23:00) - biospace.com/
AFIB | $0.1744 6.47% 6.08% 730K
|
Health Technology
|
| O: 47.51%
H: 4.03%
C: -12.1%
results
Mirati Therapeutics to Present New Research at the 2022 ASCO Annual Meeting Showcasing Clinical Advances of Treating KRASG12C-Mutated Lung Cancer with Investigational Adagrasib
Published: 2022-04-27 (Crawled : 23:00) - biospace.com/
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: 0.21%
H: 0.88%
C: -2.15%
krasg12 research therapeutics asco cancer
Ultragenyx to Host Conference Call for First Quarter 2022 Financial Results and Corporate Update
Published: 2022-04-27 (Crawled : 23:00) - biospace.com/
RARE F | $43.38 -1.65% -1.68% 770K
|
Health Technology
|
| O: 0.0%
H: 1.11%
C: 0.34%
conference
Aligos Therapeutics to Announce First Quarter 2022 Results May 4, 2022
Published: 2022-04-27 (Crawled : 23:00) - biospace.com/
ALGS | $0.781 -0.76% -0.77% 240K
|
Health Technology
|
| O: -0.77%
H: 6.24%
C: -1.57%
therapeutics results
Minerva Surgical to Announce First Quarter 2022 Financial Results
Published: 2022-04-27 (Crawled : 23:00) - biospace.com/
UTRS | $0.51 77.27% 560
|
|
| O: -1.27%
H: 0.0%
C: -7.07%
results
AMGEN REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS
Published: 2022-04-27 (Crawled : 23:00) - biospace.com/
REGN | $893.66 -0.84% -0.84% 450K
|
Health Technology
|
| O: -0.77%
H: 0.56%
C: -0.97%
BGNE | $131.94 0.06% 0.06% 130K
|
Health Technology
|
| O: 1.64%
H: 6.35%
C: 1.76%
AMGN | $262.77 -0.49% -0.49% 2M
|
Health Technology
|
| O: -0.33%
H: 1.2%
C: -0.1%
results
CareDx to Report First Quarter 2022 Financial Results
Published: 2022-04-27 (Crawled : 23:00) - biospace.com/
CDNA | $8.08 -2.42% -2.48% 670K
|
Health Technology
|
| O: -6.91%
H: 2.82%
C: 0.2%
report results
Zymeworks Announces Presentations at 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2022-04-27 (Crawled : 23:00) - biospace.com/
ZYME | $8.68 -1.92% -1.96% 730K
|
Health Technology
|
| O: 1.45%
H: 0.0%
C: 0.0%
Viking Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-04-27 (Crawled : 21:00) - biospace.com/
VKTX | $64.7 -2.66% -2.74% 2.4M
|
Health Technology
|
| O: 0.44%
H: 0.87%
C: -4.35%
LGND | $72.61 -7.94% -8.62% 130K
|
Health Technology
|
| O: -0.08%
H: 1.83%
C: -1.41%
therapeutics results
Opiant Pharmaceuticals Announces Positive Topline Results from Head-to-Head Pharmacodynamic Study Comparing OPNT003, Nasal Nalmefene, to Nasal Naloxone
Published: 2022-04-27 (Crawled : 21:00) - biospace.com/
OPNT | $20.65 -0.58% 0.48% 0
|
Health Technology
|
| O: 0.25%
H: 0.96%
C: -2.77%
opnt003 topline positive results
Iovance Biotherapeutics to Present Translational Data for Lifileucel in Advanced Melanoma at 2022 ASCO Annual Meeting
Published: 2022-04-27 (Crawled : 21:00) - biospace.com/
IOVA M | $11.72 -0.68% -0.68% 3.6M
|
Health Technology
|
| O: -0.2%
H: 2.67%
C: -0.59%
asco
AnaptysBio Announces Positive ANB032 (anti-BTLA agonist) Top-Line Phase 1 Data and Provides Pipeline Updates
Published: 2022-04-27 (Crawled : 21:00) - biospace.com/
ANAB | $19.84 -7.59% -8.32% 360K
|
Health Technology
|
| O: 0.18%
H: 1.23%
C: -1.1%
anb032 positive topline phase 1
Y-mAbs Announces Executive Management Changes and Provides 2022 Revenue Guidance and Financial Update
Published: 2022-04-27 (Crawled : 21:00) - biospace.com/
YMAB | $14.97 -0.93% -0.94% 410K
|
Health Technology
|
| O: -0.32%
H: 3.27%
C: -1.37%
management
Statera Biopharma and Immune Therapeutics Inc. Announce Strategic Agreement for Rights to Low Dose Naltrexone
Published: 2022-04-27 (Crawled : 21:00) - biospace.com/
IMUN | $0.093 214.52% 1.8K
|
Manufacturing
|
| O: -6.25%
H: 0.0%
C: -6.67%
biopharma therapeutics
Real-World Evidence Confirms Immediate and Ongoing Performance of the t:slim X2 Insulin Pump with Control-IQ Technology in Children and Adults
Published: 2022-04-27 (Crawled : 19:00) - biospace.com/
TNDM | $30.92 -2.61% -2.68% 1.1M
|
Health Technology
|
| O: -0.12%
H: 2.56%
C: -2.98%
ongoing children technology insulin
Adicet Bio Announces Oral Presentation of Updated ADI-001 Phase 1 Data at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2022-04-27 (Crawled : 17:00) - biospace.com/
ACET | $2.02 -11.01% -12.38% 930K
|
Health Technology
|
| O: 0.15%
H: 7.21%
C: 6.62%
adi-001 presentation phase 1
Following Gilead's Lead, J&J Takes Action Against Counterfeit HIV Drugs
Published: 2022-04-27 (Crawled : 17:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.77%
H: 0.0%
C: 0.0%
hiv drug
Cytovia Goes Public in SPAC Deal Amidst Slow Biotech IPO Environment
Published: 2022-04-27 (Crawled : 16:00) - biospace.com/
ISLE | $10.01 0.1%
|
|
| O: 0.0%
H: 0.1%
C: 0.0%
biotech deal spac
IceCure Medical Presents ICE3 Breast Cancer Trial Interim Data, Hosts Cryoablation Symposium & Conducts Hands-On ProSense® Training Sessions at the European Conference on Interventional Oncology
Published: 2022-04-27 (Crawled : 15:00) - biospace.com/
ICCM | $1.24 -3.88% -4.03% 110K
|
Manufacturing
|
| O: -1.33%
H: 5.41%
C: 0.45%
prosense conference symposium trial cancer breast cancer train
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.